Juvenile Arthritis
8
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis
Downstream Effects of Personalized 'Top-down' Participation-based Interventions Among Youth With Physical Disabilities
Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention.
Impact of Pilates Exercise in Children With Juvenile Idiopathic Arthritis
A Peer E-mentoring Intervention to Improve Employment
Effectiveness and Feasibility of a Home-based Exercise Program for Adolescents With Juvenile Idiopathic Arthritis
Clinical Investigation of the LCS® Complete Posterior Stabilized Mobile-bearing Total Knee System
Jointstrong Intervention for Juvenile Arthritis